Share
Journal Information
Most cited
Data available in articles published since the year 2014
184
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysisR. Torres-Castro, L. Vasconcello-Castillo, X. Alsina-Restoy, L. Solis-Navarro, F. Burgos, H. Puppo, J. Vilaró
Pulmonol. 2021;27:328-37
184
Open access
Open Article
148
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohortsI. Motta, R. Centis, L. D’Ambrosio, J.-M. García-García, D. Goletti, G. Gualano, F. Lipani, F. Palmieri, A. Sánchez-Montalvá, E. Pontali, G. Sotgiu, A. Spanevello, C. Stochino, E. Tabernero, M. Tadolini, M. van den Boom, S. Villa, D. Visca, G.B. Migliori
Pulmonol. 2020;26:233-40
148
Open access
143
Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicentersH. Lau, T. Khosrawipour, P. Kocbach, H. Ichii, J. Bania, V. Khosrawipour
Pulmonol. 2021;27:110-5
143
Open access
124
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
124
Open access
116
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsD. Visca, C.W.M. Ong, S. Tiberi, R. Centis, L. D’Ambrosio, B. Chen, J. Mueller, P. Mueller, R. Duarte, M. Dalcolmo, G. Sotgiu, G.B. Migliori, D. Goletti
Pulmonol. 2021;27:151-65
116
Open access
Open Article
110
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
110
Open access
107
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
107
Open access
98
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
98
Open access
92
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic reviewA. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi
Pulmonol. 2021;27:52-66
92
Open access
Open Article
63
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectivesJ.L. Boechat, I. Chora, A. Morais, L. Delgado
Pulmonol. 2021;27:423-37
63
Open access
Special content about COVID-19
- A Different Wave – Posttraumatic Stress Disorder among healthcare professionals during the COVID-19 pandemic
- COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Author's reply
- Intermittent versus equivalent constant-load cycle training in COVID-19 patients
- Impact of the COVID-19 pandemic on in-hospital diagnosis of tuberculosis in non-HIV patients
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
